Pharmaceutical Products

Generic:

Colistimethate Sodium

Therapeutic Segment:

Antibiotic

Indications:

• Treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli particularly when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
• Treat chronic chest infections in patients with cystic fibrosis.

Available as:

1 Million IU Injection
4.5 Million I.U. Injection

Generic:

Ciprofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Broncho-pulmonary infections.
• ENT infections.
• Infections of mouth, teeth and jaws.
• Uncomplicated acute cystitis.
• Complicated urinary tract infections and acute pyelonephritis.
• Bacterial prostatitis.
• Gonococcal urethritis and cervicitis.
• Gastrointestinal infections.
• Infections of the bones and joints.
• Wound and soft tissue infections.
• Peritonitis.

Available as:

250mg Tablets
500mg Tablets
200mg/100ml I.V. Infusion

Generic:

Ceftazidime

Therapeutic Segment:

Antibiotic

Indications:

Severe infections e.g. septicaemia, bacteraemia, peritonitis, meningitis infections in immunosuppressed patients, infections in patients in intensive care, e.g. infected burns.

• Respiratory tract infections including lung infections in cystic fibrosis.
• Ear, nose and throat infections
• Urinary tract infections.
• Urinary tract infections
• Skin and soft tissue infections
• Gastrointestinal, biliary and abdominal infections
• Bone and joint infections
• Infections associated with haemo and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD).
• Prophylaxis: Prostatic surgery (transurethral reaction).

Available as:

1g I.M. / I.V. Injection

Generic:

Ceftriaxone sodium

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Uncomplicated acute cystitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections.

Available as:

250mg I.M. / I.V. Injection
500mg I.M. / I.V. Injection
1g I.V. Injection
2g I.V. Injection

Generic:

Cefepime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections including pneumonia and bronchitis.
• Urinary tract infections including pyelonephritis.
• Skin and skin structure infections.
• Intra-abdominal infections including peritonitis and biliary tract infections.
• Gynecologic infections.
• Septicemia.
• Empiric treatment in febrile neutropenia.
• Surgical prophylaxis in intra-abdominal surgeries.

Available as:

500mg I.M. / I.V. Injection
1g I.M. / I.V. Injection

Generic:

Cefotaxime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Tonsillitis, pneumonia, bronchitis, bronchial extensions, secondary infections of chronic respiratory tract diseases, abscess of lung and emphysema.
• Pyelitis, urinary tract infections, gonorrhea, prostatitis, adnexitis, endometritis, infections around uterus and bartholinitis.
• Meningitis, septicemia and bacterial endocarditis.
• Osteomyelitis and septic arthritis.
• Peritonitis, cholecystitis and cholangitis.
• Prophylaxis for patients with impaired immune function.

Available as:

250mg Injection
500mg Injection
1g Injection

Generic:

Ceftriaxone

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Tonsillitis, pneumonia, bronchitis, bronchial extensions, secondary infections of chronic respiratory tract diseases, abscess of lung and emphysema.
• Pyelitis, urinary tract infections, gonorrhea, prostatitis, adnexitis, endometritis, infections around uterus and bartholinitis.
• Meningitis, septicemia and bacterial endocarditis.
• Osteomyelitis and septic arthritis.
• Peritonitis, cholecystitis and cholangitis.
• Prophylaxis for patients with impaired immune function.

Available as:

1g I.V. Injection

Generic:

Moxifloxacin

Therapeutic Segment:

Antibiotic

Indications:

• Acute bacterial sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community-acquired pneumonia.
• Uncomplicated and complicated skin and skin structure infections.

Available as:

400mg Tablets

Generic:

Metronidazole

Therapeutic Segment:

Antibiotic and Antiprotozoal agent

Indications:

• The prophylaxis of post-operative infections due to sensitive anaerobic bacteria particularly species of bacteroides and anaerobic Streptococci, during abdominal, gynecological gastrointestinal or colorectal surgery which carries a high risk of occurrence of this type of infection.
• The solution may also be used in combination with an anti-biotic active against aerobic bacteria.
• The treatment of severe intra-abdominal and gynecological infections in which sensitive anaerobic bacteria particularly Bacteroides and anaerobic Streptococci have been identified or are suspected to be the cause.

Available as:

500mg/100mL Intravenous Infusion.

Generic:

Ofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute bacterial exacerbations of chronic bronchitis.
• Community acquired Pneumonia.
• Uncomplicated skin and skin structure infections.
• Acute, uncomplicated urethral and cervical gonorrhea.
• Nongonococcal urethritis and cervicitis.
• Pelvic inflammatory disease.
• Uncomplicated cystitis.
• Complicated urinary tract infections and prostatitis.

Available as:

200mg Tablets

Generic:

Ceftriaxone

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections

Available as:

250mg I.M. Injection
1g I.V. Injection

Generic:

Levofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute maxillary sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community acquired pneumonia.
• Typhoid and paratyphoid fever.
• Complicated and uncomplicated skin and skin structure infections.
• Complicated and uncomplicated urinary tract infections.
• Acute pyelonephritis.

Available as:

250mg Tablets
500mg Tablets
750mg Tablets

Generic:

Meropenem

Therapeutic Segment:

Antibiotic

Indications:

• Severe pneumonia.
• Broncho-pulmonary infections in cystic fibrosis.
• Complicated urinary tract infections.
• Complicated intra-abdominal infections.
• Intra and postpartum infections.
• Complicated skin ad soft tissue infections.
• Septicemia.
• Febrile neutropenia.
• Acute bacterial meningitis.

Available as:

500mg Injection
1g Injection

Generic:

Cefixime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Uncomplicated urinary tract infections.
• Otitis media.
• Pharyngitis and tonsillitis.
• Acute bronchitis and acute exacerbation of chronic bronchitis.
• Uncomplicated gonorrhea (cervical/urethral).

Available as:

200mg Capsules
400mg Capsules

100mg /5ml Suspension
200mg /5ml DS Suspension

Generic:

Clarithromycin

Therapeutic Segment:

Antibiotic

Indications:

Indicated for treatment of infections due to susceptible organisms. Such infections include:

• Lower respiratory tract infections (e.g. bronchitis, pneumonia)
• Upper respiratory tract infections (e.g. pharyngitis, sinusitis)
• Acute otitis media in children
• Skin and soft tissue infections (e.g. folliculitis, cellulitis, erysipelas)
• Disseminated or localized mycobacterial infections due to MAC
• To eradicate Helicobacter pylori in treatment regimens for peptic ulcer disease
• It has been tried in protozoal infections, including toxoplasmosis
• To prevent disseminated Mycobacterium Avium Complex (MAC) disease in patients with advanced HIV infection
• As an alternative treatment to penicillins for prophylaxis of endocarditis

Available as:

250mg Tablets
500mg Tablets

Generic:

Cefoperazone + Sulbactam

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Upper and lower respiratory tract infections.
• Upper and lower urinary tract infections.
• Peritonitis, cholecystitis, cholangitis and other intra-abdominal infections.
• Septicemia.
• Meningitis.
• Skin and soft tissue infections.
• Bone and joint infections.
• Pelvic inflammatory disease, endometritis, gonorrhea and other infections of genital tract.

Available as:

1g I.M. / I.V. Injection
2g I.M. / I.V. Injection

Generic:

Vancomycin HCl

Therapeutic Segment:

Antibiotic

Indications:

Vancotic is indicated for serious infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci and penicillin-allergic patients.
Vancotic is used to treat staphylococcal endocarditis, infections including septicemia, bone infections, lower respiratory tract infections, and skin & skin structure infections.

Available as:

500mg I.V. Injection
1g I.V. Injection

Generic:

Piperacillin+Tazobactam

Therapeutic Segment:

Antibiotic

Indications:

Vinzat is indicated for the treatment of infections caused by susceptible organisms.

• Appendicitis, complicated by rupture with peritonitis and/or abscess formation in children. Because of its broad spectrum of activity, Vinzat is used for urinary tract infections, bone and joint infections, severe vaginal infections, stomach infections, skin infections, and pneumonia.

Available as:

2.25g I.V. Injection
4.5g I.V. Injection

Generic:

Moxifloxacin

Therapeutic Segment:

Antibiotic

Indications:

indicated for the treatment of adults (>18 years of age) with mild, moderate and severe infections caused by susceptible strains of microorganisms in the conditions listed below:

• Acute bacterial exacerbation of chronic bronchitis
• Community acquired pneumonia
• Uncomplicated skin and skin structure infections
• Complicated intra-abdominal infections (including polymicrobial infections such as abscesses).
• Complicated skin and skin structure infections (including diabetic foot infections).

Available as:

400mg/250ml I.V. Infusion

Generic:

Linezolid

Therapeutic Segment:

Antibiotic

Indications:

• Pneumonia.
• Community-Acquired Pneumonia.
• Skin and Skin Structure Infections.
• Methicillin-Resistant & Vancomycin-Resistant Infections.

Available as:

400mg Tablets
600mg Tablets
100mg/5ml Suspension
600mg/300ml Infusion

Generic:

Azithromycin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis/tonsillitis and acute otitis media in children).
• Uncomplicated skin and skin structure infections and acne.
• Sexually transmitted diseases (uncomplicated urethritis and cervicitis).
• Pelvic inflammatory diseases in patients who require initial intravenous therapy.
• Chlamydial infections.

Available as:

250mg Tablets
500mg Tablets
100mg/5ml Oral Suspension

Generic:

Ebastine

Therapeutic Segment:

Anti-allergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

10mg Tablets
20mg Tablets

Generic:

Montelukast

Therapeutic Segment:

Anti-asthmatic

Indications:

• Prophylaxis and chronic treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.

Available as:

5mg Tablets
10mg Tablets
4mg Sachets

Generic:

Loratadine

Therapeutic Segment:

Anti-allergic

Indications:

• Allergic rhinitis.
• Chronic urticaria and other allergic dermatological disorders.

Available as:

10mg Tablets

Generic:

Desloratadine

Therapeutic Segment:

Anti-allergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

5mg Tablets
0.5mg/ml Syrup

Generic:

Empagliflozin

Therapeutic Segment:

Antidiabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• When diet and exercise alone do not provide adequate glycemic control in patients for whom the use of metformin is considered inappropriate due to intolerance.
• In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.

Available as:

10mg Tablets
25mg Tablets

Generic:

Empagliflozin + Metformin HCl

Therapeutic Segment:

Anti-Diabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients insufficiently controlled on their maximally tolerated dose of metformin alone.
• In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products.
• In patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Available as:

12.5mg+500mg Tablets
12.5mg+850mg Tablets
12.5mg+1000mg Tablets

Generic:

Empagliflozin + Linagliptin + Metformin HCl

Therapeutic Segment:

Anti-Diabetic

Indications:

• Improves glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.

Available as:

10mg/5mg/1000mg Tablets
12.5mg/2.5mg/1000mg Tablets
25mg/5mg/1000mg Tablets

Generic:

Sotagliflozin

Therapeutic Segment:

Cardiometabolic

Indications:

Reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with:

• Heart failure or
• Type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.

Available as:

200mg Tablets

Generic:

Vildagliptin

Therapeutic Segment:

Anti-Diabetic

Indications:

• The treatment of type 2 diabetes mellitus in adults as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindication or intolerance.
• As dual oral therapy in combination with metformin, in patients with insufficient glycemic control despite a maximally tolerated dose of monotherapy with metformin.
• As triple oral therapy in combination with sulfonylureas and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.
• Also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.

Available as:

50mg Tablets

Generic:

Vildagliptin + Metformin HCI

Therapeutic Segment:

Anti-Diabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients whose diabetes is not adequately controlled on metformin or vildagliptin as separate tablets.

Available as:

50mg + 500mg Tablets
50mg + 850mg Tablets
50mg + 1000mg Tablets

Generic:

Glimepiride

Therapeutic Segment:

Anti-Diabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled by diet and exercise alone.

Available as:

1mg Tablets
2mg Tablets
3mg Tablets
4mg Tablets

Generic:

Glimepiride+Metformin HCI

Therapeutic Segment:

Anti-Diabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise in patients whose diabetes is not adequately controlled with glimepiride or metformin alone, or for those patients who have initially responded to glimepiride or metformin alone and require additional glycemic control.

Available as:

2mg + 500mg Tablets

Generic:

Semaglutide

Therapeutic Segment:

Antidiabetic/Weight Management

Indications:

• Type 2 diabetes
• Weight management
• Cardiovascular risk reduction

Available as:

3mg, 7mg and 14mg Tablets

0.25mg, 0.5mg and 1mg Prefilled Syringe

Generic:

Ferric Carboxymaltose

Therapeutic Segment:

Hematinic

Indications:

• Treatment of iron deficiency when oral iron preparations may not be effective or cannot be used.
• Treatment of iron deficiency in patients with chronic heart failure.
• When there is a clinical need to deliver iron rapidly.

Available as:

500mg/10mL Injection

Generic:

Iron Sucrose

Therapeutic Segment:

Hematinic

Indications:

• For the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
• Iron deficiency because of other reasons (before and after surgery, final stages of pregnancy, intolerance, non-responsiveness or non-compliance to oral iron therapy, malabsorption etc).

Available as:

100mg/5mL I.V. Injection

Generic:

Iron (III) Hydroxide Polymaltose Complex

Therapeutic Segment:

Anti-anemic

Indications:

For the prevention and treatment of iron deficiency anemia:

• During pregnancy and lactation.
• In children, adolescents, women of childbearing age and adults.

Available as:

100mg Chewable Tablets
50mg/5mL Syrup

Generic:

Iron (III) Hydroxide Polymaltose Complex + Folic Acid

Therapeutic Segment:

Anti-anemic

Indications:

• For the treatment of latent and manifest iron deficiency anemia.
• To prevent iron and folic acid deficiency before, during and after pregnancy (during lactation).

Available as:

100mg + 0.35mg Chewable Tablets

Generic:

Artemether + Lumefantrine

Therapeutic Segment:

Anti-malarial

Indications:

• Treatment of adults and children with acute, uncomplicated infections due to plasmodium falciparum, including malarial infections acquired in areas where the parasites may be resistant to other anti-malarials.

Available as:

20mg+120mg Disp. Tablets
40mg+240mg Tablets
80mg+480mg Tablets
30mg+180mg Suspension

Generic:

Artemether

Therapeutic Segment:

Anti-malarial

Indications:

• Treatment of all kinds of malaria, including chloroquine-resistant malaria and first aid for fatal malaria.

Available as:

80mg I.M. Injection

Generic:

Terbinafine

Therapeutic Segment:

Anti-fungal

Topical

Indications:

• Tinea cruris & corporis
• Tinea pedis
• Cutaneous candidiasis
• Pityriasis versicolor

Oral

Indications:

• Onychomycosis (finger & toe nails)
• Tinea cruris & corporis
• Tinea pedis
• Tinea capitis

Available as:

• 125mg Tablets
• 250mg Tablets
• 1% w/w Cream

Generic:

Fluconazole

Therapeutic Segment:

Anti-fungal

Indications:

• Acute or recurrent vaginal candidiasis.
• Mucosal candidiasis e.g oropharyngeal, oesophageal, bronchopulmonary, mucocutaneous & denture sore mouth.
• Athlete's foot (Tinea pedis), ringworm (Tinea corporis), Tinea cruris, Tinea versicolor & dermal candida infection.
• Cryptococcosis, Cryptococcal meningitis and infections of other sites (pulmonary & cutaneous).
• Prevention of fungal infection in immuno-compromised patients.

Available as:

150mg Capsules

Generic:

Letrozole

Therapeutic Segment:

Aromatase Inhibitor

Indications:

• For the treatment of all stages of hormone receptor-positive breast cancer in postmenopausal women.

Available as:

2.5mg Tablets

Generic:

Amlodipine

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Prophylaxis of chronic stable angina pectoris.
• Confirmed or suspected vasospastic angina.

Available as:

5mg Tablets
10mg Tablets

Generic:

Aprocitentan

Therapeutic Segment:

Antihypertensive

Indications:

• In hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs.
• Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Available as:

12.5mg Tablets

Generic:

Empagliflozin

Therapeutic Segment:

Anti-Diabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• When diet and exercise alone do not provide adequate glycemic control in patients for whom the use of metformin is considered inappropriate due to intolerance.
• In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.

Available as:

10mg Tablets
25mg Tablets

Generic:

Rosuvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

5mg Tablets
10mg Tablets
20mg Tablets

Generic:

Sotagliflozin

Therapeutic Segment:

Cardiometabolic

Indications:

Reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with:

• Heart failure or
• Type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.

Available as:

200mg Tablets

Generic:

Atorvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

10mg Tablets
20mg Tablets
40mg Tablets

Generic:

Losartan potassium

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.
• Diabetic neuropathy with an elevated serum creatinine and proteinuria in type 2 diabetic patients.

Available as:

25mg Tablets
50mg Tablets

Generic:

Losartan potassium + Hydrochlorothiazide

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.

Available as:

50mg+12.5mg Tablets

Generic:

Nebivolol

Therapeutic Segment:

Antihypertensive / Cardiovascular agent

Indications:

• In hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with other antihypertensive agents.
• Stable mild and moderate chronic heart failure, in addition to standard therapies, in elderly patients 70 years old or above.

Available as:

2.5mg Tablets
5mg Tablets
10mg Tablets

Generic:

Clopidogrel

Therapeutic Segment:

Platelet Aggregation Inhibitor

Indications:

• It is indicated for the reduction of thrombotic events in patients with recent myocardial infarction, acute coronary syndrome, recent stroke or established peripheral arterial disease.

Available as:

75mg Tablets

Generic:

Clopidogrel + Acetylsalicylic Acid

Therapeutic Segment:

Antiplatelet Agent / Cardiovascular Therapyr

Indications:

• For the prevention of ischemic events, myocardial infarction, stroke and cardiovascular death in patients with Acute Coronary Syndrome (ACS).

Available as:

75mg + 75mg Tablets

Generic:

Amlodipine + Valsartan

Therapeutic Segment:

Antihypertensive

Indications:

• For treating hypertension.
• For patients whose BP is not controlled on either monotherapy.
• For patients who are likely to need multiple drugs to achieve their BP goals.

Available as:

5mg/80mg Tablets

5mg/160mg Tablets

10mg/160mg Tablets

Generic:

Dexlansoprazole

Therapeutic Segment:

Gastroprokinetic

Indications:

Indicated in patients 12 years of age and older:

• For healing of all grades of Erosive Esophagitis (EE) for up to eight weeks.
• To maintain healing of EE and relief of heartburn for up to six months.
• For the treatment of heartburn associated with symptomatic non-erosive Gastro Esophageal Reflux Disease (GERD) for four weeks.

Available as:

30mg Capsules
60mg Capsules

Generic:

Esomeprazole

Therapeutic Segment:

Anti-ulcerant

Indications:

• Gastroesophageal reflux disease (GERD) & symptomatic GERD without esophagitis.
• Erosive esophagitis (EE), long-term management of patients with healed esophagitis to prevent relapse.
• H. pylori eradication to reduce the risk of duodenal ulcer.
• Short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients 1 month to 17 years of age, as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.
• Risk reduction of re-bleeding of gastric or duodenal ulcers following therapeutic endoscopy for acute bleeding of gastric or duodenal ulcers in adults.

Available as:

20mg Capsules
40mg Capsules
40mg I.V. Injection / Infusion

Generic:

Famotidine

Therapeutic Segment:

Anti-ulcerant

Indications:

• Duodenal ulcers.
• Prevention of recurrence of duodenal ulcers.
• Benign gastric ulcer.
• Gastroesophageal reflux.
• Hypersecretory conditions such as Zollinger-Ellison syndrome.

Available as:

20mg Tablets
40mg Tablets

Generic:

Itopride Hydrochloride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Functional dyspepsia.
• Non-ulcer dyspepsia (Chronic gastritis).

Available as:

50mg Tablets

Generic:

Prucalopride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Treatment of chronic idiopathic constipation (CIC) in adults.

Available as:

1mg Tablets
2mg Tablets

Generic:

Resmetirom

Therapeutic Segment:

Hepatoprotective

Indications:

• For the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).

Available as:

60mg Tablets

80mg Tablets

100mg Tablets

Generic:

Omeprazole

Therapeutic Segment:

Anti-ulcerant

Indications:

• Gastroesophageal reflux disease (GERD).
• Gastric and duodenal ulcers.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Eradication of H.pylori infection associated with peptic ulcer disease.
• Zollinger-Ellison syndrome.
• Dyspepsia.
• Prophylaxis of acid aspiration.

Available as:

20mg Capsules
40mg Capsules
40mg Infusion

Generic:

Omeprazole + Sodium Bicarbonate

Therapeutic Segment:

Anti-ulcerant

Indications:

• Treatment of gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD and treatment of erosive esophagitis (EE) which has been diagnosed by endoscopy.
• Short-term treatment of active duodenal ulcer.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Short-term treatment of active benign gastric ulcer.
• Maintenance treatment of healing of erosive esophagitis (EE).
• Reduction treatment of risk of upper gastrointestinal bleeding in critically ill patients.

Available as:

40mg + 1680mg Sachet

Generic:

Domperidone

Therapeutic Segment:

Gastroprokinetic

Indications:

• Dyspeptic symptom complex that is often associated with delayed gastric emptying, gastroesophageal reflux and esophagitis.
• Prevention and treatment of nausea and vomiting.

Available as:

10mg Tablets

Generic:

Levosulpiride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Gastroesophageal reflux disease (GERD).
• Irritable bowel syndrome.
• Dyspeptic syndrome due to delayed gastric emptying.
• Vertigo.
• Schizophrenia.

Available as:

25mg Tablets
50mg Tablets

Generic:

Vonoprazan

Therapeutic Segment:

Gastroprokinetic

Indications:

Indicated for:

• Gastric ulcer, duodenal ulcer, reflux esophagitis, prevention of recurrence of gastric or duodenal ulcer during low-dose aspirin administration, prevention of recurrence of gastric or duodenal ulcer during non-steroidal anti-inflammatory drug (NSAID) administration.
• Adjunct to Helicobacter pylori eradication in the following settings: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphatic tissue (MALT) lymphoma, idiopathic thrombocyto-penic purpura, the stomach after endoscopic resection of early stage gastric cancer or Helicobacter pylori gastritis.

Available as:

10mg Tablets
20mg Tablets

Generic:

Cyproterone Acetate + Ethinylestradiol

Therapeutic Segment:

Hormone Therapy

Indications:

• Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhea).
• Hirsutism (excessive hair growth) in women of reproductive age.
• As a hormonal contraceptive.

Available as:

2mg + 35mcg Tablets

Generic:

Sodium Chloride

Therapeutic Segment:

Hospital Solutions

Indications:

• Indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.

Available as:

0.9g/100mL I.V. Infusion

Generic:

Sildenafil Citrate

Therapeutic Segment:

Male Health

Indications:

• For the treatment of erectile dysfunction in men.

Available as:

50mg Tablets
100mg Tablets

Generic:

Tizanidine

Therapeutic Segment:

Muscle Relaxant

Indications:

• Treatment of painful muscle spasms.
• Treatment of spasticity due to neurological disorders.

Available as:

2mg Tablets
4mg Tablets

Generic:

Paracetamol

Therapeutic Segment:

Analgesic/Antipyretic

Indications:

• The short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.

Available as:

1g/100mL Infusion

Generic:

Tramadol HCl + Paracetamol

Therapeutic Segment:

Analgesic

Indications:

• Management of moderate to severe painful conditions.

Available as:

37.5mg+325mg Tablets

Generic:

Piroxicam-β-cyclodextrin

Therapeutic Segment:

Analgesic

Indications:

• For a variety of acute painful conditions requiring anti-inflammatory and analgesic activity, including rheumatoid arthritis, osteo-arthritis (arthrosis, degenerative joint disease), ankylosing spondylitis, musculoskeletal and joint disorders, gout, in soft-tissue disorders, and in postoperative pain.

Available as:

20mg Tablets

Generic:

Diclofenac Sodium

Therapeutic Segment:

Analgesic

Indications:

• For the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, low back pain, frozen shoulder, tendinitis, tenosynovitis, bursitis, strains, sprains, and acute gout.
• To control the pain and inflammation in orthopedic, dental and minor surgeries.
• In children, for the treatment of juvenile chronic arthritis.

Available as:

50mg Tablets
100mg SR Tablets
75mg I.M. / I.V. Injection

Generic:

Diclofenac Potassium

Therapeutic Segment:

Analgesic

Indications:

Short-term treatment for the following acute conditions:

• Post-traumatic pain, inflammation, and swelling, e.g., due to sprains.
• Post-operative pain, inflammation, and swelling, e.g., following dental or orthopedic surgery.
• Painful and/or inflammatory conditions in gynecology, e.g., primary dysmenorrhea or adnexitis.
• Migraine attacks.
• Painful syndromes of the vertebral column.
• Non-articular rheumatism.
• As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g., pharyngotonsillitis, otitis.

Available as:

75mg Tablets

Generic:

Tamsulosin HCI

Therapeutic Segment:

Urology

Indications:

• Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Available as:

0.4mg Capsules

Generic:

Cholecalciferol

Therapeutic Segment:

Vitamin and Vitamin Analogue

Indications:

• For the prevention and treatment of vitamin D deficiency.
• Recommended in rickets due to vitamin D resistance.

Available as:

5mg (200,000 IU) /mL Oral / I.M. Injection

Generic:

Semaglutide

Therapeutic Segment:

Antidiabetic/Weight Management

Indications:

• Type 2 diabetes
• Weight management
• Cardiovascular risk reduction

Available as:

3mg, 7mg and 14mg Tablets

0.25mg, 0.5mg and 1mg Prefilled Syringe